The identified biomarkers and notable cancer-related pathways provide important insights into how tumors grow, with specific genes, such as HER2, TP53, MMP11, MYBL2, and members of the CLDN family, showing strong connections to cancer progression. This evidence concerns the gene MYBL2 and cancer.